IRIS
RUSSO, Giuseppina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.475
NA - Nord America 6.323
AS - Asia 4.022
SA - Sud America 1.344
AF - Africa 123
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 2
Totale 19.296
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.177
RU - Federazione Russa 3.853
SG - Singapore 1.693
BR - Brasile 1.164
CN - Cina 1.129
IE - Irlanda 915
SE - Svezia 803
HK - Hong Kong 473
IT - Italia 432
DE - Germania 327
FR - Francia 254
VN - Vietnam 221
PL - Polonia 212
UA - Ucraina 206
FI - Finlandia 155
GB - Regno Unito 155
IN - India 110
AR - Argentina 60
MX - Messico 60
BD - Bangladesh 56
IQ - Iraq 52
CA - Canada 50
ID - Indonesia 42
TR - Turchia 39
ZA - Sudafrica 38
AT - Austria 34
EC - Ecuador 33
BE - Belgio 31
JP - Giappone 30
CO - Colombia 25
UZ - Uzbekistan 23
ES - Italia 22
NL - Olanda 20
VE - Venezuela 20
KE - Kenya 17
MA - Marocco 16
PK - Pakistan 16
AZ - Azerbaigian 15
CL - Cile 14
JO - Giordania 13
MY - Malesia 13
TN - Tunisia 12
PH - Filippine 11
SA - Arabia Saudita 11
NP - Nepal 10
UY - Uruguay 10
CI - Costa d'Avorio 9
HN - Honduras 9
IR - Iran 9
LV - Lettonia 9
DZ - Algeria 8
KZ - Kazakistan 8
PY - Paraguay 8
DO - Repubblica Dominicana 7
JM - Giamaica 7
AL - Albania 6
IL - Israele 6
PE - Perù 6
RO - Romania 6
AU - Australia 5
CH - Svizzera 5
CZ - Repubblica Ceca 5
EG - Egitto 5
SY - Repubblica araba siriana 5
AM - Armenia 4
BY - Bielorussia 4
ET - Etiopia 4
KG - Kirghizistan 4
KR - Corea 4
PS - Palestinian Territory 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
BO - Bolivia 3
CR - Costa Rica 3
LB - Libano 3
LT - Lituania 3
NG - Nigeria 3
NI - Nicaragua 3
PT - Portogallo 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
GE - Georgia 2
LK - Sri Lanka 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
OM - Oman 2
PA - Panama 2
QA - Qatar 2
SN - Senegal 2
SV - El Salvador 2
TW - Taiwan 2
AO - Angola 1
BN - Brunei Darussalam 1
BW - Botswana 1
CG - Congo 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
Totale 19.279
Salva come PNG Salva come JPEG
Città #
Ashburn 1.123
Moscow 1.120
Singapore 957
Dublin 913
Chandler 674
Dallas 524
Hong Kong 471
Jacksonville 420
Beijing 394
Nyköping 383
San Jose 274
Warsaw 207
Los Angeles 173
The Dalles 170
Princeton 166
Lauterbourg 142
Medford 142
Messina 132
Cambridge 128
Dearborn 126
Des Moines 121
Ann Arbor 110
São Paulo 96
New York 77
Munich 72
Boardman 69
Buffalo 67
Ho Chi Minh City 66
Council Bluffs 59
San Mateo 55
Bremen 54
Jinan 52
Tianjin 52
Redondo Beach 51
Wilmington 50
Shenyang 46
Hanoi 43
Santa Clara 42
Guangzhou 36
Belo Horizonte 33
Woodbridge 32
Brussels 31
Rio de Janeiro 31
Nuremberg 30
Turku 30
Frankfurt am Main 29
Tokyo 29
Seattle 26
Catania 25
Orem 25
Pune 25
Baghdad 24
Jakarta 24
Montreal 23
Nanjing 23
Brasília 22
Brooklyn 22
Dong Ket 22
Hebei 22
Houston 22
Tashkent 22
Curitiba 21
Haikou 21
Milan 19
Chicago 18
Mexico City 18
Campinas 17
Rome 17
Johannesburg 16
London 16
Mumbai 16
Nairobi 16
Porto Alegre 16
Denver 15
Shanghai 15
Vienna 15
Amsterdam 14
Baku 14
Falls Church 14
Poplar 14
Zhengzhou 14
Chennai 13
Istanbul 13
Lancaster 13
Ningbo 13
Phoenix 13
Quito 13
San Francisco 13
Shenzhen 13
Amman 12
Boston 12
Helsinki 12
Ribeirão Preto 12
Hangzhou 11
Manchester 11
Salvador 11
Stockholm 11
Taizhou 11
Cape Town 10
Charlotte 10
Totale 10.982
Salva come PNG Salva come JPEG
Nome #
Adverse Drug Reactions in Hospitalized patients: results of the FORWARD (Facilitation of reporting in hospital Ward) study. 266
As Time Goes by: Anxiety Negatively Affects the Perceived Quality of Life in Patients With Type 2 Diabetes of Long Duration 226
Twelve-month treatment with Liraglutide ameliorates Visceral Adiposity Index and common cardiovascular risk factors in type 2 diabetes outpatients. 211
THIONAMIDES-RELATED VASCULITIS IN AUTOIMMUNE THYROID DISORDERS: REVIEW OF CURRENT LITERATURE AND CASE REPORTS 197
Livelli di TSH e parametri metabolici in soggetti eutiroidei con diabete di tipo 2 196
High Prevalence of Arcobacter Carriage in Older Subjects with Type 2 Diabetes 195
Effects of the antagomiRs 15b and 200b on the altered healing pattern of diabetic mice 193
Influence of peroxisome proliferator-activated receptor-γ exon 2 and exon 6 and insulin receptor substrate (IRS)-1 Gly972Arg polymorphisms on insulin resistance and beta-cell function in southern mediterranean women with polycystic ovary syndrome 189
Apparent Treatment Resistant Hypertension, Blood Pressure Control and the Progression of Chronic Kidney Disease in Patients with Type 2 Diabetes. 188
.Frequence of FDB in a hypercholesterolemic population from east Sicily 187
Pimozide and pancreatic cancer in diabetic chorea: a case report 185
EFFETTO DEL POLIMORFISMO CETP TAQ1B SUL PROFILO LIPIDICO E SULLE SOTTOPOLAZIONI HDL NELLE DONNE CON E SENZA DIABETE DI TIPO 2 183
Diabetic neuropathy is not associated with homocysteine, folate, vitamin B12 levels, and MTHFR C677T mutation in type 2 diabetic outpatients taking metformin. 183
Central nervous system vasculitis after starting methimazole in a woman with Graves' disease 181
Age and gender affect the relation between methylenetetrahydrofolate reductase C677T genotype and fasting plasma homocysteine concentrations in the Framingham Offspring Study cohort 178
Ischemic stroke and reperfusion therapies in diabetic patients 175
Very High Frequency of the Polymorphism for the Insulin Receptor Substrate 1 (IRS-1) at Codon 972 (Glycine972Arginine) in Southern Italian Women with Polycystic Ovary Syndrome. 172
Over time evaluation of glycaemic control in direct-acting antiviral-treated hepatitis C virus/diabetic individuals with chronic hepatitis or with cirrhosis 167
Elevata prevalenza della colonizzazione da parte di Arcobacter spp. in soggetti asintomatici con diabete di tipo 2 163
Age- and Gender-Related Differences in LDL-Cholesterol Management in Outpatients with Type 2 Diabetes Mellitus. 163
Antihypertensive Treatment in Diabetic Kidney Disease: The Need for a Patient-Centered Approach. 161
The Management of Diabetes Mellitus in Patients with Chronic Kidney Disease: A Population-Based Study in Southern Italy 158
Correlates of total homocysteine plasma concentration in type 2 diabetes 157
Ipertransaminasemia persistente in una coorte di pazienti diabetici di tipo 2: prevalenza e correlazioni cliniche 155
Gender differences in new hypoglycemic drug effects on renal outcomes: a systematic review 154
Effetti di un anno di trattamento con liraglutide sui principali fattori di rischio cardiovascolare in pazienti con diabete mellito di tipo 2. 153
Clinical correlates of persistently elevated liver enzymes in type 2 diabetic outpatients 153
Genomic Variations Affecting Biological Effects of Statins 151
MTHFR C677T polymorphism, folate status and colon cancer risk in acromegalic patients. 151
Association of the Sst-I polymorphism at the APOC3 gene locus with variations in lipid levels, lipoprotein subclass profiles and coronary heart disease risk: the Framingham offspring study 149
Effetto della menopausa sui livelli di omocisteina e sul polimorfismo C677T della metilenetetraidrofolato reduttasi nelle donne con diabete mellito di tipo 2 149
IPERTRANSAMINASEMIAQ PERSISTENTE IN UNA COORTE DI PAZIENTI DIABETICI DI TIPO 2: PREVALENZA E CORRELAZIONI CLINICHE. 148
Differente impatto dei polimorfismi APOC3 SST1 e CETP TAQ1B sul profilo lipidico e lipoproteico nelle donne con e senza diabete di tipo 2 148
GENDER DIFFERENCES IN THE RELATIONSHIP BETWEEN METABOLIC SYNDROME AND ANGER EXPRESSION. 148
Association of a Common Polymorphism in the Methylenetetrahydrofolate Reductase (MTHFR) Gene with Bone Phenotypes Depends on Plasma Folate Status 146
A CASE OF OSTEOPOROTIC FRACTURES IN WOLFRAM SYNDROME 146
Factors Associated with Beta-Cell Dysfunction in Type 2 Diabetes: The BETADECLINE Study 144
Influence of high-normal serum TSH levels on major cardiovascular risk factors and Visceral Adiposity Index in euthyroid type 2 diabetic subjects. 144
Fattori di rischio cardiovascolare lipidici e non lipidici in donne diabetiche di tipo 2 con e senza cardiopatia ischemica 143
Effetti di un anno di trattamento con liraglutide sui principali fattori di rischio cardiovascolare in pazienti con diabete mellito di tipo 2 143
Artificial intelligence and big data in diabetes care: A position statement of the Italian association of medical diabetologists 143
[Hyperhomocysteinemia and cardiovascular risk in diabetes mellitus] 141
Gender differences in diabetic kidney disease: Focus on hormonal, genetic and clinical factors 141
Fracture Risk in Type 2 Diabetes: Current Perspectives and Gender Differences 140
Antihyperglycemic treatment in patients with type 2 diabetes in Italy: The impact of age and kidney function 140
Analoghi del Glucagon-like peptide-1: cosa ci riserva il futuro. 138
Association of kidney disease measures with risk of renal function worsening in patients with hypertension and type 2 diabetes 138
HDL subclasses and the common CETP TaqIB variant predict the incidence of microangiopatic complications in type 2 diabetic women: A 9 years follow-up study 138
Livelli plasmatici di resistina e proteina C- reattiva nelle donne: ruolo del diabete di tipo 2 e della menopausa. 137
Fattori di rischio cardiovascolare lipidici e non lipidici in donne diabetiche di tipo 2 con e senza cardiopatia ischemica. 136
Corrigendum to “Fracture Risk in Type 2 Diabetes: Current Perspectives and Gender Differences” 136
EFFETTO DEL DIABETE E DELLA MENOPAUSA SUL PROFILO LIPIDICO E LA DISTRIBUZIONE DELLE SOTTOPOPOLAZIONI HDL NELLE DONNE 135
Livelli di TSH e parametri metabolici in soggetti diabetici di tipo 2 eutiroidei 135
3. High-density lipoprotein as a coronary heart disease risk factor and gene mutations affecting high-density lipoprotein cholesterol levels: Results from the Framingham Heart Study 134
Gli Standard di Cura terzo step: incretina + metformina. 132
Atherogenic dyslipidemia and diabetic nephropathy 131
Fattori di rischio cardiovascolare lipidici e non lipidici in donne diabetiche di tipo 2 con e senza cardiopatia ischemica 130
Type 2 diabetes and cardiovascular risk in women. 129
Resistin levels and inflammatory and endothelial dysfunction markers in obese postmenopausal women with type 2 diabetes mellitus 127
ELEVATA PREVALENZA DELLA COLONIZZAZIONE DA PARTE DI ARCOBACTER P: IN SOGGETTI ASINTOMATICI CON DIABETE DI TIPO 2. 125
Impact of Sex and Gender on Clinical Management of Patients with Advanced Chronic Liver Disease and Type 2 Diabetes 124
Lipid and non-lipid cardiovascular risk factors in postmenopausal type 2 diabetic women with and without coronary heart disease. 124
Recombinant Insulin in Type 2 Diabetes Treatment: Where Are We Now? 123
Livelli di resistina nelle donne diabetiche di tipo 2 con e senza cardiopatia ischemica. 122
Diabetic kidney disease in the elderly: Prevalence and clinical correlates 121
Mild hyperhomocysteinemia and the common C677t polymorphism of methylene tetrahydrofolate reductase gene are not associated with the metabolic syndrome in Type 2 diabetes. 120
Livelli di omocisteina, vitamina B12 e folati in soggetti con diabete mellito di tipo 2 con o senza neuropatia diabetica. Ruolo della metformina 118
Livelli plasmatici dei marcatori di flogosi nelle donne: influenza della menopausa e del diabete 117
High Prevalence of Severe Hepatic Fibrosis in Type 2 Diabetic Outpatients Screened for Non-Alcoholic Fatty Liver Disease 116
RUOLO DELL'IPEROMOCISTEINEMIA E DEL GENOTIPO C677T DEL GENE DELLA METILENE TEDRAIDROFOLATO REDUTTASI (MTHFR)IN UNA POPOLAZIONE DI DIABETICI DI TIPO 2 CON E SENZA SINDROME METABOLICA 114
A prediction model to assess the risk of egfr loss in patients with type 2 diabetes and preserved kidney function: the amd annals initiative 113
Visceral adiposity index as an indicator of cardiometabolic risk in patients treated for craniopharyngioma 113
CAPTURE: a multinational,cross-sectional study of cardiovascular disease prevalence in adults with type 2 diabetes across 13 countries. 113
Achievement of therapeutic targets in patients with diabetes and chronic kidney disease: Insights from the Associazione Medici Diabetologi Annals initiative 112
Five-year predictors of insulin initiation in people with type 2 diabetes under real-life conditions 112
Predictors of treatment response to liraglutide in type 2 diabetes in a real-world setting 112
Inflammatory markers in women with a recent history of gestational diabetes mellitus 111
Skin lesions in diabetes mellitus: prevalence and clinical correlations. 111
Necrobiosis lipoidica associated with Hashimoto's thyroiditis and positive detection of ANA and ASMA autoantibodies 111
IPEROMOCISTEINEMIA E RISCHIO CARDIOVASCOLARE NEL DIABETE: FANTASIA O REALTA'? 110
Simvastatin prevents vascular complications in the chronic reactive oxygen species murine model of systemic sclerosis 108
Plasma triglycerides and HDL-C levels predict the development of diabetic kidney disease in subjects with type 2 diabetes: The AMD annals initiative 107
The Burden of Structured Self-Monitoring of Blood Glucose on Diabetes-Specific Quality of Life and Locus of Control in Patients with Noninsulin-Treated Type 2 Diabetes: The PRISMA Study. 107
The legacy effect of hyperglycemia and early use of SGLT-2 inhibitors: a cohort study with newly-diagnosed people with type 2 diabetes 106
POLIMORFISMO DEL GENE DELL'APOLIPOPROTEINA E E PATOLOGIA COLELITIASICA IN UNA POPOLAZIONE DEL SUD ITALIA 104
Biphasic insulin aspart in the treatment of type 2 diabetes mellitus 103
Inhibition of lipid peroxidation restores impaired vascular endothelial growth factor expression and stimulates wound healing and angiogenesis in the genetically diabetic mouse. 103
Beta cell stress in a 4-year follow-up of patients with type 2 diabetes: A longitudinal analysis of the BetaDecline Study 103
Long-Term Influence of Locus of Control and Quality of Life on Metabolic Profile in Elderly Subjects with Type 2 Diabetes 102
Ruolo dell’ipercisteinemia e del genotipo C677T del gene della metilene tetraidrifolato redattasi (MTHFR) in una popolazione di diabetici di tipo 2 con e senza Sindrome Metabolica 101
Influence of menopause and cholesteryl ester transfer protein (CETP) TaqIB polymorphism on lipid profile and HDL subpopulations distribution in women with and without type 2 diabetes. 101
Mild hyperhomocysteinemia, C677T polymorphism on methylenetetrahydrofolate reductase gene and the risk of macroangiopathy in type 2 diabetes: a prospective study 100
Long-Term Effectiveness of Liraglutide for Treatment of Type 2 Diabetes in a Real-Life Setting: A 24-Month, Multicenter, Non-interventional, Retrospective Study. 100
determinants of total homocysteine plasma levels in type 2 diabetes 100
LE DISLIPIDEMIE NEL PAZIENTE DIABETICO 99
Frequence of FDP in a hypercholesterolemic population from East Sicily 99
Methotrexate Increases Skeletal Muscle GLUT4 Expression and Improves Metabolic Control in Experimental Diabetes 98
The "lively" cytokines network in beta-Thalassemia Major-related osteoporosis. 97
Influence of CETP Taq IB polymorphism on lipid profile and HDL subpopulations distribution in women with and without diabetes 97
GLP-1 Receptor Agonists and Kidney Protection 97
Totale 13.854
Salva come PNG Salva come JPEG
Categoria #
all - tutte 67.541
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.541
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202165 0 0 0 0 0 0 0 0 0 0 0 65
2021/20221.102 7 96 10 46 34 10 88 41 25 276 123 346
2022/20232.655 193 195 137 214 205 251 25 174 1.151 19 62 29
2023/2024608 47 90 44 56 42 134 19 42 3 27 18 86
2024/20253.329 50 52 73 207 168 125 84 653 822 201 303 591
2025/20269.338 425 564 666 651 806 1.991 1.225 1.122 1.160 425 173 130
Totale 19.698